Bactiguard enters new partnership in Europe
Bactiguard has entered a distribution agreement for Belgium and the Netherlands with Ecomed Services NV (“Ecomed”), a leading provider of innovations in infection control in the Benelux countries.
“Ecomed is a specialized distributor of medical devices to the public and private hospitals in Belgium and the Netherlands. They grow their business by adding products that cater to the needs of the healthcare sector, in particular infection control, which is at the top of the agenda in many countries. We are confident that they have the competence and resources required to strengthen the Bactiguard brand in this region”, says Christian Kinch, CEO.
“We have not been satisfied with the sales development in Belgium for some time and have therefore been looking for a new distributor. By teaming up with Ecomed, an experienced and well connected partner, we also enter the Netherlands and expand our European coverage”, Christian Kinch continues.
Ecomed is a privately owned company and a leading provider of innovations in infection control to the healthcare sector in the Benelux countires.
“We are excited to enter into partnership with Bactiguard and add their innovative solutions for infection prevention to our portfolio. We strongly believe in Bactiguard’s technology to effectively reduce hospital acquired infections and consumption of antibiotics throughout the Benelux region,” says Bart Leemans, CEO of Ecomed.
For further information, please contact:
Cecilia Edström, CFO, cell phone: +46 72 226 23 28
About Bactiguard
Bactiguard is a Swedish medical device company with a mission to save lives. To achieve this mission we develop and supply infection protection solutions which reduce the risk of healthcare associated infections and the use of antibiotics. This way, we save significant costs for healthcare and the society at large. The Bactiguard technology prevents bacterial adhesion and biofilm formation on medical devices. Bactiguard offers the technology through licence agreements and our BIP (Bactiguard Infection Protection) portfolio of products. Through our licence partner CR Bard, urinary catheters with Bactiguard’s coating are market leading in the USA and Japan. Bactiguard’s own product portfolio of urinary catheters, endotracheal tubes and central venous catheters prevent some of the most common infections, which appear in the urinary tract, the blood stream and the respiratory tract.
Bactiguard is in a strong expansion phase in the European markets, China, India and the Middle East as well by establishing license agreements in new therapeutic areas. The company has about 60 employees around the world. Its headquarters and one of two production facilities are located in Stockholm, the other one in Malaysia. Bactiguard is listed on Nasdaq Stockholm.
Read more about how Bactiguard saves lives on www.bactiguard.com
Tags: